Maxim Integrated Products (MXIM): Cutting Estimates In Anicipation Of Weak Guidance - RBC
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
RBC Capital analyst, Amit Daryanani, reiterated his Sector Perform rating on shares of Maxim Integrated Products (NASDAQ: MXIM) and cut estimates for the December quarter to reflect Note 7 headwinds heading into the Sep-qtr EPS call.
The analyst sees limited downside given the high dividend yield and potential take-out, but the stock is unlikely to work higher unless revenues increase, a scenario that seems unlikely given Samsung's challenges.
No change to the price target of $40.
Shares of Maxim Integrated Products closed at $37.87 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- M&T Bank (MTB) PT Raised to $165 at FBR Capital Following 4Q Beat
- Drexel Hamilton Reiterates Buy on IBM (IBM) Following 4Q Report
- IBM (IBM): Closer Look Shows The - Jefferies
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change
Related EntitiesRBC Capital
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!